This blog is still in BETA
We are aware of any formatting errors. These stories are automatically pulled from RSS feeds. Due to the automated nature of the post, some images may appear small, and some links may not be clickable until our staff has had the opportunity to manicure the postings. Thank you for understanding.
This blog is still in BETA
We are aware of any formatting errors. These stories are automatically pulled from RSS feeds. Due to the automated nature of the post, some images may appear small, you may find duplicate stories, and some links may not be clickable until our staff has had the opportunity to manicure the postings. Thank you for understanding.
A new hemophilia treatment has just been approved by the FDA, and it has its roots in the Philadelphia region. The drug is called Obizur, and much of its development was done by Octagen, a Bala Cynwyd, Pa. biotechnology company. The drug is now owned ...>
from Hemophilia - Google News http://ift.tt/1wvKaNf via IFTTT
ADVOCATES FOR PERSONS WITH HIV/AIDS, HEMOPHILIA, HCV, AND SICKLE CELL
MONITORING THE BLOOD SUPPLY AND PROTECTING PATIENT RIGHTS SINCE 1989
The Committee of Ten Thousand is a grass-roots, peer-led, education, advocacy and support organization. The majority of our constituency is persons with hemophilia who contracted HIV/AIDS from tainted blood products. We work in solidarity with all communities affected by the HIV/AIDS pandemic. COTT advocates for disenfranchised chronic disease communities, especially those communities dependent on a safe national blood supply. We are dedicated to the belief that persons with HIV/AIDS and all chronic diseases can lead productive and healthy lives.
Find us on Facebook
Stay in the debate! Join our discussion group!
Stay up to date! Join the mailing list!
Powered by Squarespace
